🚀 VC round data is live in beta, check it out!
Farmaceutica Remedia Valuation Multiples
Discover revenue and EBITDA valuation multiples for Farmaceutica Remedia and similar public comparables like Balsm Alofoq, iZafe Group, Jin Medical International, Prolight Diagnostics and more.
Farmaceutica Remedia Overview
About Farmaceutica Remedia
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.
Founded
1991
HQ
Employees
230
Website
Sectors
Financials (FY)
EV
$7M
Farmaceutica Remedia Financials
Farmaceutica Remedia reported last fiscal year revenue of $173M and EBITDA of $4M.
In the same fiscal year, Farmaceutica Remedia generated $14M in gross profit, $4M in EBITDA, and $2M in net income.
Farmaceutica Remedia P&L
In the most recent fiscal year, Farmaceutica Remedia reported revenue of $173M and EBITDA of $4M.
Farmaceutica Remedia expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $173M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $14M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 8% | XXX | XXX | XXX |
| EBITDA | — | XXX | $4M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 2% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 2% | XXX | XXX | XXX |
| Net Profit | — | XXX | $2M | XXX | XXX | XXX |
| Net Margin | — | XXX | 1% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Farmaceutica Remedia Stock Performance
Farmaceutica Remedia has current market cap of $19M, and enterprise value of $7M.
Market Cap Evolution
Farmaceutica Remedia's stock price is $0.21.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7M | $19M | 0.1% | XXX | XXX | XXX | $0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFarmaceutica Remedia Valuation Multiples
Farmaceutica Remedia trades at 0.0x EV/Revenue multiple, and 1.6x EV/EBITDA.
Farmaceutica Remedia Financial Valuation Multiples
As of April 4, 2026, Farmaceutica Remedia has market cap of $19M and EV of $7M.
Equity research analysts estimate Farmaceutica Remedia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Farmaceutica Remedia has a P/E ratio of 9.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $19M | XXX | $19M | XXX | XXX | XXX |
| EV (current) | $7M | XXX | $7M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 2.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 0.5x | XXX | XXX | XXX |
| P/E | — | XXX | 9.8x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 1.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Farmaceutica Remedia Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Farmaceutica Remedia Margins & Growth Rates
Farmaceutica Remedia's revenue in the last fiscal year grew by 2%.
Farmaceutica Remedia's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.0M for the same period.
Farmaceutica Remedia Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 2% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 12% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 6% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Farmaceutica Remedia Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Balsm Alofoq | XXX | XXX | XXX | XXX | XXX | XXX |
| iZafe Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Jin Medical International | XXX | XXX | XXX | XXX | XXX | XXX |
| Prolight Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ortivus | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Farmaceutica Remedia M&A Activity
Farmaceutica Remedia acquired XXX companies to date.
Last acquisition by Farmaceutica Remedia was on XXXXXXXX, XXXXX. Farmaceutica Remedia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Farmaceutica Remedia
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFarmaceutica Remedia Investment Activity
Farmaceutica Remedia invested in XXX companies to date.
Farmaceutica Remedia made its latest investment on XXXXXXXX, XXXXX. Farmaceutica Remedia invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Farmaceutica Remedia
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Farmaceutica Remedia
| When was Farmaceutica Remedia founded? | Farmaceutica Remedia was founded in 1991. |
| Where is Farmaceutica Remedia headquartered? | Farmaceutica Remedia is headquartered in Romania. |
| How many employees does Farmaceutica Remedia have? | As of today, Farmaceutica Remedia has over 230 employees. |
| Is Farmaceutica Remedia publicly listed? | Yes, Farmaceutica Remedia is a public company listed on Bucharest Stock Exchange. |
| What is the stock symbol of Farmaceutica Remedia? | Farmaceutica Remedia trades under RMAH ticker. |
| When did Farmaceutica Remedia go public? | Farmaceutica Remedia went public in 2006. |
| Who are competitors of Farmaceutica Remedia? | Farmaceutica Remedia main competitors are Balsm Alofoq, iZafe Group, Jin Medical International, Prolight Diagnostics. |
| What is the current market cap of Farmaceutica Remedia? | Farmaceutica Remedia's current market cap is $19M. |
| What is the current revenue of Farmaceutica Remedia? | Farmaceutica Remedia's last fiscal year revenue is $173M. |
| What is the current EV/Revenue multiple of Farmaceutica Remedia? | Current revenue multiple of Farmaceutica Remedia is 0.0x. |
| Is Farmaceutica Remedia profitable? | No, Farmaceutica Remedia is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.